{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:56:29Z","timestamp":1780696589759,"version":"3.54.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.contraception.2010.04.012","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T04:34:26Z","timestamp":1274416466000},"page":"418-427","source":"Crossref","is-referenced-by-count":79,"title":["Contraceptive vaginal rings: a review"],"prefix":"10.1016","volume":"82","author":[{"given":"Vivian","family":"Brache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anibal","family":"Faundes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.04.012_bib1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(06)69480-4","article-title":"Family planning; the unfinished agenda","volume":"368","author":"Cleland","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.04.012_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0015-0282(16)37333-2","article-title":"Contraceptive effect of varying dosages of progestogen in silastic vaginal rings","volume":"21","author":"Mishell","year":"1970","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.04.012_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/endo-78-1-208","article-title":"Passage of steroids through silicone rubber","volume":"78","author":"Dzuik","year":"1966","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2010.04.012_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1210\/jcem-14-12-1564","article-title":"The physiologic effectiveness of progesterone vaginal suppositories","volume":"14","author":"Greenblatt","year":"1954","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.04.012_bib5","first-page":"186","article-title":"The absorption of conjugated estrogens and sodium estrone sulfate from the vagina","volume":"63","author":"Widholm","year":"1974","journal-title":"Ann Chir Gynecol Fenn"},{"key":"10.1016\/j.contraception.2010.04.012_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.04.012_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0039-128X(00)00175-6","article-title":"Progestin-only contraceptive rings","volume":"65","author":"Brache","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2010.04.012_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0010-7824(82)90132-9","article-title":"Pharmacokinetics and pharmacodynamic investigation with vaginal devices releasing levonorgestrel at a constant near zero order rate","volume":"26","author":"Landgren","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0010-7824(89)90133-9","article-title":"The in vivo release characteristics of a multi-compartment vaginal ring releasing 3-keto-desogetrel","volume":"40","author":"Jackson","year":"1989","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonorgestrel and ethinyl estradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2010.04.012_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9378(99)70718-0","article-title":"Causes and consequences of oral contraceptive noncompliance","volume":"180","author":"Rosenberg","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0010-7824(81)90006-8","article-title":"Acceptability of the contraceptive vaginal ring by rural and urban population in two Latin American countries","volume":"24","author":"Faundes","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2307\/1965397","article-title":"User's perception of the contraceptive vaginal ring: a field study in Brazil and the Dominican Republic","volume":"14","author":"Hardy","year":"1983","journal-title":"Stud Fam Plann"},{"key":"10.1016\/j.contraception.2010.04.012_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0010-7824(98)00145-0","article-title":"Clinical acceptability of an ethylene-vinyl-acetate non-medicated vaginal ring","volume":"59","author":"Roumen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0010-7824(94)00005-H","article-title":"The acceptability of a combined estrogen\/progestogen contraceptive vaginal ring","volume":"51","author":"Weisberg","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(02)00514-0","article-title":"The combined contraceptive vaginal ring, NuvaRing\u00ae: an international study of user acceptability","volume":"67","author":"Novak","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 3 \u03bcg of ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0002-9378(78)90438-6","article-title":"Clinical performance and endocrine profile with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel","volume":"130","author":"Mishell","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0010-7824(78)80014-6","article-title":"Pituitary and gonadal function during the use of norgestrel\u2013estradiol vaginal rings","volume":"18","author":"Toivonen","year":"1978","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0010-7824(81)90002-0","article-title":"Levonorgestrel and estradiol release from an improved contraceptive vaginal ring","volume":"24","author":"Jackanicz","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0010-7824(81)90003-2","article-title":"A multicenter study of levonorgestrel\u2013estradiol contraceptive vaginal rings: I. Use effectiveness. An international comparative trial","volume":"24","author":"Sivin","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0010-7824(81)90004-4","article-title":"A multicenter study of levonorgestrel\u2013estradiol contraceptive vaginal rings: II. Subjective and objective measures of effects. An international comparative trial","volume":"24","author":"Sivin","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0010-7824(81)90005-6","article-title":"A multicenter study of levonorgestrel\u2013estradiol contraceptive vaginal rings: III. Menstrual patterns. An international comparative trial","volume":"24","author":"Sivin","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib24","first-page":"471","article-title":"Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring: II. Serum lipoproteins and apolipoproteins","volume":"24","author":"Ahren","year":"1981","journal-title":"Contraception."},{"key":"10.1016\/j.contraception.2010.04.012_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0010-7824(81)90010-X","article-title":"Lipoprotein patterns in women in Santo Domingo using a levonorgestrel\/estradiol contraceptive ring","volume":"24","author":"Robertson","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0010-7824(81)90008-1","article-title":"The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol","volume":"24","author":"Roy","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0015-0282(16)59238-3","article-title":"Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques","volume":"47","author":"Adams","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.04.012_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0010-7824(94)90012-4","article-title":"Dose-finding study of a contraceptive ring releasing norethindrone acetate\/ethinyl estradiol","volume":"50","author":"Ballagh","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0010-7824(94)90011-6","article-title":"A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol","volume":"50","author":"Ballagh","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0010-7824(97)00133-9","article-title":"Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring","volume":"56","author":"Weisberg","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(99)00036-0","article-title":"A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol","volume":"59","author":"Weisberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-7824(99)00035-9","article-title":"Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring","volume":"59","author":"Weisberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0010-7824(92)90101-X","article-title":"Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles","volume":"46","author":"Alvarez-Sanchez","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0010-7824(90)90095-D","article-title":"A contraceptive vaginal ring releasing EE and the progestin ST1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry","volume":"42","author":"Laurikka-Routti","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2004.08.010","article-title":"Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial","volume":"71","author":"Sivin","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.contraception.2004.12.015","article-title":"Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone\u00ae progestogen\u2013ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen","volume":"72","author":"Fraser","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.contraception.2004.12.014","article-title":"Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone\u00ae progestogen\/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen","volume":"72","author":"Weisberg","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0010-7824(00)00081-0","article-title":"Vaginal epithelial surface appearances in women using vaginal rings for contraception","volume":"61","author":"Fraser","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.contraception.2005.06.071","article-title":"Feasibility study of Nestorone\u00ae\u2013ethinylestradiol vaginal contraceptive ring for emergency contraception","volume":"73","author":"Croxatto","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0010-7824(90)90016-O","article-title":"Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol","volume":"42","author":"Apter","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0010-7824(90)90083-8","article-title":"Contraception with a vaginal ring releasing 3-keto-desogestrel and ethinylestradiol","volume":"42","author":"Olsson","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0010-7824(90)90004-F","article-title":"Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings","volume":"42","author":"Timmer","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib43","first-page":"12","article-title":"Practical experience in the UK with an oestrogen\/progestogen contraceptive vaginal ring","volume":"18","author":"Kirkman","year":"1992","journal-title":"Br J Fam Plann"},{"key":"10.1016\/j.contraception.2010.04.012_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0028-2243(93)90101-H","article-title":"The 3-keto-desogestrel\/ethinylestradiol ring: a new parenteral form of hormonal contraception","volume":"49","author":"Schindeler","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2010.04.012_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0010-7824(90)90141-H","volume":"41","author":"World Health Organization","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0010-7824(90)90142-I","volume":"41","author":"World Health Organization","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(90)90143-J","volume":"41","author":"World Health Organization","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0010-7824(90)90144-K","volume":"41","author":"World Health Organization","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0028-2243(93)90252-8","article-title":"Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring","volume":"48","author":"Bounds","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2010.04.012_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0010-7824(01)00199-8","article-title":"Ovarian function during use of vaginal rings delivering three different doses of NES","volume":"63","author":"Brache","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib51","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0039-128X(00)00125-2","article-title":"Vaginal rings for contraception in lactating women","volume":"65","author":"Massai","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2010.04.012_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0026-0495(80)90117-1","article-title":"Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate","volume":"29","author":"Buckman","year":"1980","journal-title":"Metabolism"},{"key":"10.1016\/j.contraception.2010.04.012_bib53","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0002-9378(85)90664-7","article-title":"Comparison of hepatic impact of oral and vaginal administration of ethynil estradiol","volume":"151","author":"Goebelsmann","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0015-0282(00)01640-X","article-title":"Endocrine and clinical effects of micronized estradiol administered vaginally or orally","volume":"75","author":"Tougerman","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.04.012_bib55","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.04.012_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib57","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","article-title":"Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","article-title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross over study","volume":"123","author":"Fleischer","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2010.04.012_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2008.07.004","article-title":"Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis","volume":"78","author":"Jensen","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0010-7824(85)80005-6","article-title":"Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of progesterone-releasing vaginal rings","volume":"32","author":"Diaz","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(99)00057-8","article-title":"Preregistration study on the safety and contraceptive efficacy of the progesterone-releasing vaginal ring in Chilean nursing women","volume":"60","author":"Massai","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(97)00135-2","article-title":"Fertility regulation in nursing women: IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and copper T 380A intrauterine devices","volume":"56","author":"Diaz","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(97)00008-5","article-title":"Contraception for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380 IUD","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib64","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.contraception.2005.05.004","article-title":"Extended use of a progesterone-releasing vaginal ring in nursing women: a Phase II clinical trial","volume":"72","author":"Massai","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0015-0282(01)01689-2","article-title":"Use of the novel combined vaginal ring NuvaRing for ovulation inhibition","volume":"75","author":"Mulders","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.04.012_bib66","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/humrep\/deh493","article-title":"Ovarian function with the contraceptive vaginal ring or an oral contraceptive: randomized study","volume":"19","author":"Duijkers","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.04.012_bib67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humrep\/16.3.469","article-title":"Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl estradiol","volume":"16","author":"Roumen","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.04.012_bib69","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0029-7844(02)02124-5","article-title":"Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring","volume":"100","author":"Dieben","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib70","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":"Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib71","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.contraception.2007.01.013","article-title":"The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials","volume":"75","author":"Roumen","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib72","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/TCRM.S1964","article-title":"Review of the combined contraceptive vaginal ring, (NuvaRing\u00ae)","volume":"4","author":"Roumen","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.contraception.2010.04.012_bib73","series-title":"In: The Cochrane Library","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews","author":"Lopez","year":"2010"},{"key":"10.1016\/j.contraception.2010.04.012_bib74","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.contraception.2005.11.003","article-title":"Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus oral contraceptive","volume":"73","author":"Schafer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000298338.58511.d1","article-title":"Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial","volume":"111","author":"Creinin","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib76","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.AOG.0000136082.59644.13","article-title":"A comparison between the vaginal ring and oral contraceptives","volume":"104","author":"Veres","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib77","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0010-7824(92)90163-N","article-title":"The effects of a combined contraceptive vaginal ring releasing ethinylestradiol and 3-ketodesogestrel on vaginal flora","volume":"45","author":"Davies","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.contraception.2005.05.008","article-title":"Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive","volume":"72","author":"O'Connell","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib79","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/humrep\/del162","article-title":"Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 \u03bcg ethinyl estradiol and 3 mg drospirenone","volume":"21","author":"Milsom","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.04.012_bib80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.contraception.2004.01.004","article-title":"The combined contraceptive vaginal ring (NuvaRing\u00ae) and lipid metabolism: a comparative study","volume":"69","author":"Tuppurainen","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib81","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13625180400007199","article-title":"A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal thyroid function","volume":"9","author":"Duijkers","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.04.012_bib82","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/humrep\/dei117","article-title":"The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women","volume":"20","author":"Massai","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.04.012_bib83","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.contraception.2005.05.005","article-title":"The combined contraceptive vaginal ring (NuvaRing\u00ae) and endometrial histology","volume":"72","author":"Bulten","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib84","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humrep\/deh604","article-title":"Superior cycle control with contraceptive vaginal ring compared with an oral contraception containing 30 \u03bcg ethinylestradiol and 150 \u03bcg levonorgestrel: a randomization trial","volume":"20","author":"Oddsson","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.04.012_bib85","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mob.2002.121103","article-title":"Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel\/ethinyl estradiol","volume":"186","author":"Bjarnadottir","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.AOG.0000164483.13326.59","article-title":"Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive","volume":"106","author":"Westhoff","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib87","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib88","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.contraception.2006.10.009","article-title":"Bleeding patterns of women using extended regimens of the contraceptive vaginal ring","volume":"75","author":"Barreiros","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.04.012_bib89","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring. A randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.04.012_bib90","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2009.05.004","article-title":"Extended regimens of the vaginal contraceptive ring: cycle control","volume":"80","author":"Guazzelli","year":"2009","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T20:54:15Z","timestamp":1544475255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0010782410001496"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.04.012","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}